Ibex Medical Analytics and UPMC Join Forces for Advancing AI-based Prostate Cancer Diagnostics

TEL AVIV, Israel, July 24, 2018 /PRNewswire/ -- Ibex Medical Analytics, a pioneering developer of AI-powered cancer diagnostics, is announcing today its research collaboration with UPMC and digital pathology expert Dr. Liron Pantanowitz, Professor of Pathology and Biomedical Informatics and Vice Chairman of Pathology Informatics at UPMC Shadyside.


In this collaboration, UPMC and Ibex will apply the Ibex Second Readâ„¢ (SR) system on prostate core needle biopsies (PCNBs) from UPMC to further validate the performance characteristics of the AI-driven system in prostate cancer diagnosis.

The Ibex SR system has recently been announced as the first AI-driven diagnostic application in pathology to be applied in a clinical setting. It is deployed in the pathology institute of Maccabi Healthcare Services, one of the largest healthcare providers in Israel and Ibex's strategic partner.

"The advent of digital pathology enables the implementation of AI-driven technologies to ensure more accurate and rapid cancer diagnosis in pathology institutes. We believe that systems such as the one developed by Ibex have an important role in advancing routine anatomic pathology practice. We will be assessing the performance of the Ibex Second Read system to determine its potential for implementation at UPMC," stated Dr. Pantanowitz.

"We are excited to be collaborating with UPMC, a world-renowned center for cancer diagnostics. This collaboration will enable us to further demonstrate our system's validity and is a significant milestone in our journey to make pathology labs more accurate and efficient, leveraging cutting edge big data and machine learning technology," said Joseph Mossel, CEO of Ibex Medical Analytics.

About Ibex Medical Analytics
Ibex Medical Analytics is developing an AI-driven diagnostic system that helps pathologists deliver more efficient, metric-driven, objective and accurate diagnoses. It combines AI, data science, image analysis and machine learning technologies and applies them to cancer diagnostics in digital pathology, striving to improve patient outcomes and quality of life.
For more information visit us at www.ibex-ai.com

About UPMC
A $16 billion world-renowned health care provider and insurer, Pittsburgh-based UPMC is inventing new models of patient-centered, cost-effective, accountable care. UPMC provides more than $900 million a year in benefits to its communities, including more care to the region's most vulnerable citizens than any other health care institution. The largest nongovernmental employer in Pennsylvania, UPMC integrates 80,000 employees, more than 30 hospitals, 600 doctors' offices and outpatient sites, and a 3.4 million-member Insurance Services Division, the largest medical insurer in western Pennsylvania. As UPMC works in close collaboration with the University of Pittsburgh Schools of the Health Sciences, U.S. News & World Report consistently ranks UPMC Presbyterian Shadyside on its annual Honor Roll of America's Best Hospitals. UPMC Enterprises functions as the innovation and commercialization arm of UPMC, and UPMC International provides hands-on health care and management services with partners around the world.
For more information, go to UPMC.com.

Ibex Medical Analytics media contact:
Maya Dror Melamed


View original content:http://www.prnewswire.com/news-releases/ibex-medical-analytics-and-upmc-join-forces-for-advancing-ai-based-prostate-cancer-diagnostics-300685631.html

SOURCE Ibex Medical Analytics


Back to news